000			01425nam a2200157Ia 4500
008			220515s9999||||xx |||||||||||||| ||und||
020			_a9780230638242
050			_aQW 45 .R24 2009
100			_aRaghunath, D.
245		0	_aAntimicrobial resistance - the modern epidermic: current status and research issues
260			_aNew Delhi _bMacmillan publishers India Ltd. _c2009
300			_axxxviii, 407p.
500			_aStates that Emergence of antibiotic resistant pathogens all over the world is becoming a global problem. The infectious diseases which were thought to have been conquered with the discovery of antibiotics, are back. This is no longer a problem of the developing countries alone because with the rapid travel, international trade. etc., infections have disseminated across the borders. The burden of antibiotic resistance continues to increase and is acknowledged to be a major threat to the treatment of infectious diseases, particularly among patients in hospitals. In the present era of practice of evidence based medicine, there are enough data available to suggest that the risk of adverse outcomes has been found to be higher in patients with infections caused by antibiotic-resistant organisms compared with that by susceptible strains of the same pathogen, even after adjustment for underlying co-morbidities.
650			_aDrug Resistance, Microbial|Anti-Bacterial Agents|Genetics
942			_2lcc _cBK
999			_c7418 _d7418